Research Alliance Corp III: Trails Edge holds 9% stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Research Alliance Corp III (RACC) was the subject of an amended ownership report stating that Trails Edge Biotechnology Master Fund, LP directly held 822,500 Class A ordinary shares, or 9.0% of the class, as of September 30, 2026. Its investment manager, Trails Edge Capital Partners, LP, and Ortav Yehudai, Chief Investment Officer of Trails Edge Capital Partners, may each be deemed to beneficially own those same shares. Yehudai exercises voting and investment discretion over them.
Key Figures
Key Terms
beneficially own financial
Sole Voting Power financial
Sole Dispositive Power financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.